Patents Assigned to Microdermis Corporation
  • Patent number: 9629875
    Abstract: Disclosed are sporicidal compositions, and methods of use thereof. The sporicidal compositions contain water, an organic solvent, and a spore-germinating agent containing an iodide source, a citrate source or both. The compositions have sporicidal activity against, e.g., Clostridium difficile spores. The sporicidal compositions can be used alone, or can form part of a disinfecting composition or an antiseptic composition.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: April 25, 2017
    Assignee: Microdermis Corporation
    Inventors: Peter J. Lentini, Dawn Lembo
  • Patent number: 9084821
    Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.
    Type: Grant
    Filed: April 22, 2013
    Date of Patent: July 21, 2015
    Assignee: Microdermis Corporation
    Inventor: Griscom Bettle, III
  • Publication number: 20130251763
    Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.
    Type: Application
    Filed: April 22, 2013
    Publication date: September 26, 2013
    Applicant: Microdermis Corporation
    Inventor: Griscom BETTLE, III
  • Patent number: 8536228
    Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: September 17, 2013
    Assignee: Microdermis Corporation
    Inventors: Griscom Bettle, III, William S. Coury
  • Publication number: 20130121953
    Abstract: The disclosure describes a composition including about 4 weight percent to about 12 weight percent of povidone-iodine complex, about 0.1 weight percent to about 2 weight percent of a tertiary amide, tertiary amide salt, and/or tertiary amide hydrate, about 0.5 weight percent to about 2 weight percent of an emollient with low iodine reactivity, at least one surfactant; and water; wherein the composition has a pH ranging from about 2.0 to about 3.5.
    Type: Application
    Filed: October 31, 2012
    Publication date: May 16, 2013
    Applicant: MICRODERMIS CORPORATION
    Inventor: Microdermis Corporation
  • Publication number: 20120022165
    Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.
    Type: Application
    Filed: September 30, 2011
    Publication date: January 26, 2012
    Applicant: MICRODERMIS CORPORATION
    Inventors: Griscom Bettle, III, William S. Coury
  • Patent number: 8101163
    Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.
    Type: Grant
    Filed: December 3, 2009
    Date of Patent: January 24, 2012
    Assignee: Microdermis Corporation
    Inventor: Griscom Bettle, III
  • Patent number: 7893285
    Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-30 fatty alcohol, monoglyceride or the reaction products thereof.
    Type: Grant
    Filed: December 3, 2009
    Date of Patent: February 22, 2011
    Assignee: Microdermis Corporation
    Inventor: Griscom Bettle, III
  • Patent number: 7888393
    Abstract: The present invention is directed to transdermal compositions and the uses thereof. These compositions include at least one of the following components: a C1-C6 dialkyl, C12-C30 dialkyl quaternary ammonium salt, a C12-C30 fatty acid, a nitrogenous organic base, C12-C30 fatty alcohol, monoglyceride or the reaction products thereof.
    Type: Grant
    Filed: April 13, 2010
    Date of Patent: February 15, 2011
    Assignee: Microdermis Corporation
    Inventor: Griscom Bettle, III